Last October, I wrote for this publication about the emergence of Antibody-Drug Conjugates (ADCs) for cancer, based on my father’s experience being treated with Padcev for bladder cancer. A few months later, I posted on Twitter that, while Padcev had stopped working for my father, he had since started on another ADC called Trodelvy. His… Read More
The advent of new weight loss drugs has a huge impact on everyone in South Park. When Cartman is denied access to the life-changing medicine,…
The success or failure of many technology platforms — including in particular health tech platforms — rests with a largely obscure role of outsized importance:…
The success or failure of many technology platforms — including in particular health tech platforms — rests with a largely obscure role of outsized importance:…
Companies at the frontiers of science and medicine, developing new therapies for patients, are working on one of the most challenging endeavors known to humanity.…
Is the Climb to Fight Cancer/Fred Hutchinson Cancer Center a 501(c)(3) nonprofit institution and is my donation tax-deductible? Yes. Climb to Fight Cancer is an…
Drug development remains an incredibly expensive endeavor. Much of the cost can be attributed to late-stage clinical trial failures. The burden is borne first and…
Living in innovative domains like biomedical research requires an appreciation for the exceptional, the outlier. You might even argue that the goal of innovators –…
[Editor’s Note: this letter was drafted by female biotech leaders in response to the Supreme Court’s Dobbs decision. It was co-signed by more than 65…
Last October, I wrote for this publication about the emergence of Antibody-Drug Conjugates (ADCs) for cancer, based on my father’s experience being treated with Padcev…
Show The Focus Group with Sarah Longwell, Ep Unfiltered and Uncut: Special Episode – May 9, 2022
